Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 14 results for "dpco"

It said that the issue of newer high-end stents being

"The clause 15 of the Drug Price Control Order (DPCO) clearly states that any manufacturer should apply about the new product with evidence for its superiority to fix the ceiling price. DNA, 2 months ago

1 images for "dpco"

Times of India, 5 months ago
Rediff.com

NPPA finalises format to monitor price of 19 medical devices

Drug price regulator NPPA has finalised a new format to collect data to monitor price movement of 19 medical devices. In a notification, National Pharmaceutical Pricing Authority (NPPA) said it has come out with a new format as reaching a consensus on ...
 Business Standard1 week ago NPPA fixes, revises prices of 18 essential drugs  Business Standard2 months ago Few more drugs to come under price control: NPPA  Business Standard2 months ago Ballooning condom prices bring in regulator, 2 tiers likely  Rediff.com2 months ago

Sanofi India Q1 net profit dips 27% at Rs 60 cr

Drug firm Sanofi India today reported a 27.36 per cent dip in standalone net profit to Rs 60 crore for the first quarter ended March 31, 2017 on account of price reduction of drugs in the country and lower exports. The company had posted a net profit of Rs ...
 Business Standard2 weeks ago

NITI Aayog advocates big expenditure hike

A big portion of Centre's total expenditure in the next three years should be on roads and railways where the total spending should rise from Rs 40,000 crore in 2015-16 to over Rs 1.18 lakh crore in 2019-20, the NITI Aayog's three-year action agenda has ...
 Business Standard4 weeks ago

Medtronic to withdraw latest stents from India after price cap

After Abbott, another major multinational medical devices maker Medtronic has decided to withdraw its latest stents from India following drug price regulator NPPAs move to cap their prices. Besides, Boston Scientific has said it too may follow suit. "We have ...
 Deccan Herald1 month ago
DNA

Sanofi to boost volumes, exports as price control hits margins

With price controls continuing to crimp margins, Sanofi India expects a muted growth in the domestic market in 2017 and therefore will be focusing on volumes as well as exports. "We expect to continue to face annualised negative impact of price cuts imposed ...
 DNA1 month ago

Nifty Opens at Lifetime High as Fed Hikes Rates

Posted by Equitymaster Asian equity markets are higher today after the Federal Reserve raised rates . The Nikkei 225 is up 0.13% while the Hang Seng is up 1.05%. The Shanghai Composite is trading up by 0.63%. European & the US stocks closed higher in their ...
 Equitymaster.com2 months ago
DNA

No shortage of coronary stents: Government to Lok Sabha

There is no shortage of coronary stents in the market after substantial reduction of its price and the government is closely monitoring their availability, Lok Sabha was informed on Tuesday. "No actionable complaint regarding shortage of Coronary Stents in ...
 DNA2 months ago

Stent price control will save patients Rs 4,450 cr: Govt

The price control of stents will result in annual savings of about Rs 4,450 crore for patients, Parliament was informed today. "After the inclusion of coronary stents in the Schedule I of DPCO 2013 on December 21, 2016, the prices were fixed by the NPPA on ...
 Business Standard2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less